Paul Tudor Jones’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.07M Sell
14,100
-9,300
-40% -$4.46M 0.01% 1050
2026
Q1
$11.5M Buy
23,400
+14,400
+160% +$7.81M 0.02% 665
2025
Q4
$5.22M Sell
9,000
-11,900
-57% -$6.73M 0.01% 1131
2025
Q3
$10.1M Sell
20,900
-9,800
-32% -$4.56M 0.02% 764
2025
Q2
$12.4M Buy
30,700
+30,000
+4,286% +$12.5M 0.03% 556
2025
Q1
$348K Sell
700
-400
-36% -$217K ﹤0.01% 2507
2024
Q4
$572K Sell
1,100
-500
-31% -$275K ﹤0.01% 2135
2024
Q3
$990K Sell
1,600
-200
-11% -$118K ﹤0.01% 1626
2024
Q2
$995K Buy
1,800
+600
+50% +$344K 0.01% 1461
2024
Q1
$697K Sell
1,200
-21,900
-95% -$12.3M ﹤0.01% 1501
2023
Q4
$12.3M Buy
23,100
+14,900
+182% +$7.21M 0.1% 276
2023
Q3
$4.15M Buy
8,200
+4,400
+116% +$2.34M 0.04% 576
2023
Q2
$1.98M Buy
+3,800
New +$2.05M 0.02% 898
2023
Q1
Sell
-1,000
Closed -$550K 2951
2022
Q4
$550K Buy
+1,000
New +$530K 0.01% 1519
2022
Q1
Sell
-1,800
Closed -$1.2M 2671
2021
Q4
$1.2M Buy
+1,800
New +$1.12M 0.02% 906

Other funds holding TMO

Paul Tudor Jones's TMO Position: Q2 2026 in Review

Paul Tudor Jones increased its Thermo Fisher Scientific (TMO) stake by 426% in Q2 2026, buying an estimated $27.7M and bringing the position to 71,244 shares worth $35.7M. The position accounts for 0.05% of the portfolio, ranked #281.

Paul Tudor Jones first reported a position in TMO in Q2 2013 and has held it in 35 quarters since. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Paul Tudor Jones held 71,244 shares of Thermo Fisher Scientific worth $35.7M as of Q2 2026.
  • Paul Tudor Jones bought 57,710 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.7M.
  • Thermo Fisher Scientific made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #281 holding.
  • Paul Tudor Jones first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 35 quarters since.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.